Biotech Target N V - Jul 17, 2023 Form 4 Insider Report for Molecular Templates, Inc. (MTEM)

Role
10%+ Owner
Signature
/s/Ivo Betschart
Stock symbol
MTEM
Transactions as of
Jul 17, 2023
Transactions value $
$2,000,000
Form type
4
Date filed
7/19/2023, 03:14 PM
Previous filing
Feb 16, 2023
Next filing
Sep 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTEM Common Stock Purchase $2M +4.26M +38.02% $0.47 15.4M Jul 17, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.